Harrison Tsai, MD, PhD

Molecular Pathology, Department of Pathology
Instructor of Pediatrics, Harvard Medical School
Image
Harrison Tsai, MD, PhD

Harrison Tsai, MD, PhD

Molecular Pathology, Department of Pathology
Instructor of Pediatrics, Harvard Medical School

Medical Services

Languages
English
Certifications
American Board of Pediatrics (General)

Publications

Lymphoid malignancies in patients with Shwachman-Diamond syndrome. View Abstract
X-linked sideroblastic anemia in females. View Abstract
Primary CNS histiocytic sarcoma: Two case reports highlighting a novel MIGA2::BRAF gene fusion and genome-wide DNA methylation profiling results. View Abstract
Epithelioid Fibrous Histiocytoma Is on a Continuum With Superficial ALK-rearranged Myxoid Spindle Cell Neoplasm: A Clinicopathologic Series of 35 Cases Including Alternate RET and NTRK3 Fusions. View Abstract
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and Diagnosis. View Abstract
Vascular, adipose tissue, and/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios. View Abstract
IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. View Abstract
ETV6 fusions from insertions of exons 3-5 in pediatric hematologic malignancies. View Abstract
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. View Abstract
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. View Abstract
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged =60 years. View Abstract
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. View Abstract
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors. View Abstract
Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT). View Abstract
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. View Abstract
Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification. View Abstract
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer. View Abstract
Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes. View Abstract
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML. View Abstract
Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer. View Abstract
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy. View Abstract
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis. View Abstract
A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression. View Abstract
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer. View Abstract
The Differential Diagnosis of Medullary-Based Renal Masses. View Abstract
Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer. View Abstract
Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing. View Abstract
Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms. View Abstract
Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of Prostate Core Biopsy Images for Tumor Diagnosis. View Abstract
INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma. View Abstract
Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report. View Abstract
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement. View Abstract
A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma. View Abstract
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma. View Abstract
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications. View Abstract
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy. View Abstract
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer. View Abstract
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma. View Abstract
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination. View Abstract
Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer. View Abstract
Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens. View Abstract
A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML. View Abstract
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas. View Abstract
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer. View Abstract
Diversity of miRNAs, siRNAs, and piRNAs across 25 Drosophila cell lines. View Abstract